AI startup OpenEvidence Inc. has filed a lawsuit against Doximity Inc. in a federal court in Massachusetts, claiming that Doximity unlawfully appropriated its trade secrets. OpenEvidence accuses Doximity of “reverse-engineering” its proprietary AI technology, which it argues constitutes a breach of intellectual property rights. The lawsuit highlights the competitive tensions in the health tech sector, where innovation is often closely guarded. OpenEvidence seeks legal remedies for the alleged theft, emphasizing the importance of protecting its intellectual assets in a rapidly evolving industry. The case underscores the challenges startups face in safeguarding their innovations against larger, established companies.
Source link
Health Tech Startup Sues Online Medical Networking Platform for Alleged AI Tool Reverse Engineering

Leave a Comment
Leave a Comment